Difference of the migration ability between PTEN transfected breast cells and non-transfected cells

( views:, downloads: )
Author:
LIN Guan-ping()
HUANG Jin-wen()
ZHOU Ke-yuan()
Journal Title:
CANCER RESEARCH AND CLINIC
Issue:
Volume 18, Issue 05, 2006
DOI:
Key Word:

Abstract´╝Ü

  • [1]Stewart S L,King J B,Thompson T D,et al.Cancer mortality surveillance-united states,1990-2000[J].MMWR Surveill Summ,2004,53(3):1-108.
  • [2]Coleman R E,Rubens R D.The clinical course of bone metastases from breast cancer[J].Br J Cancer,1987,55(1):61-66.
  • [3]Dumitrescu R G,Cotarla I.Understanding breast cancer risk where do we stand in 2005[J].J Cell Mol Med,2005,9(1):208-221.
  • [4]Yoneda T.Cellular and molecular basis of preferential metastasis of breast cancer to bone[J].J Orthop Sci,2000,5(1):75-81.
  • [5]Wang P H,Yi H K,Kim D S,et al.Suppression of tumorgenicity and metastasis in B16F cells by PTEN/MMAC1/TEP1 gene[J].Cancer Lett,2001,172(1):83-91.
  • [6]Tamura M,Gu J G,Matsumoto K,et al.Inhibition of cell migration,cell spreading and focal adhesion by tumor suppression gene PTEN[J].Science,1998,280(5):1614-1617.
  • [7]Gautam A,Li Z R,Bepler G.RRM 1-induced metastasis suppression through PTEN-regulated pathways[J].Oncogene,2003,22 (14):2135-2142.
  • [8]Chung M J,Jung S H,Lee B J,et al.Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis,but not angiogenesis of breast cancer[J].Pathol Int,2004,54(1):10-15.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn